DB
Insider buying
Dan Benjamin Teleman bought $20K of NSRX stock
Dan Benjamin Teleman, Chief Executive Officer of Nasus Pharma Ltd (NSRX), bought 6,550 shares of NSRX stock worth $20K, per an SEC Form 4 filed Jun 22, 2026.
It was an open-market purchase.
The trade happened on Jun 17, 2026, 5 days before it was made public.
NSRX has moved +4.9% since the trade date, from $3.08 to $3.23 (Oct 22, 2026 close).
- Traded
- Jun 17, 2026
- Disclosed
- Jun 22, 2026
- Filing delay
- 5 days
- Price since
- +4.9%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.